Skip to content
Menu

Apnimed, Inc. APMD

Full chart Compare
Set alert

Price alert · APMD

All alert types
16.09 USD -1.16 (-6.70%)

Regular-session close

16.09 0.00 0.00%

After hours · Nov 20, 4:01 PM ET

15.95 Day range 17.73
14.16 52-week range 32.55
YTD
-35.64%
1 year
-35.64%

5D +0.14 (+0.82%)

16171819FriMonTueWedThu17.12
Market cap
669.84M
Revenue (ttm)
115.12M
Profit margin
142.10%
EPS (ttm)
13.34
Shares out
41.63M
P/E ratio
1.21
Forward P/E
-6.42
YTD return
-35.64%
1-year return
-35.64%
Volume
248.59K
Avg volume
458.53K
Open
17.08
Previous close
17.25
Day's range
15.95 – 17.73
52-week range
14.16 – 32.55
Analysts
Strong Buy
Price target
50.33 (+212.8%)
50-day average
27.74

Key statistics

200-day average
27.74
Enterprise value
1.25B
Price / sales
9.23
Revenue growth
-29.40%
Total cash
172.80M
Total debt
80.35M

Fundamental scorecard

3 of 25 checks passed on APMD’s reported financials

ValueGrowthProfitabilityHealthDividend

3of 25 checks passed

  • Value 0 of 5
  • Growth 0 of 5
  • Profitability No data
  • Financial health 3 of 5
  • Dividend No data

Statements to Sep 30, 2026.

Financials — quick view

All financials
APMD Revenue — quarterly 2.48M
APMD Net income — quarterly -29.52M
APMD EPS — quarterly -1.05

Earnings

APMD recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Sep 8, 2026Jun 30, 2026-0.486673.92+4.41+905.47%

Upgrades / downgrades

APMD analyst upgrades and downgrades
DateFirmActionFromTo
Aug 25, 2026LifeSci Capitalinit—Outperform
Aug 25, 2026Cantor Fitzgeraldinit—Overweight
Aug 25, 2026Evercore ISI Groupinit—Outperform
Aug 25, 2026B of A Securitiesinit—Buy

About Apnimed, Inc.

Apnimed, Inc. operates as a clinical pharmaceutical company that develops and manufactures novel oral therapies that address the neurobiology of sleep-related breathing diseases in global markets. It offers AD109, an oral therapy designed to treat obstructive sleep apnea (OSA) by targeting the underlying neuromuscular dysfunction. The company was incorporated in 2017 and is headquartered in Cambridge, Massachusetts.

Sector
Healthcare
Industry
Biotechnology
Country
United States
Website
apnimed.com

News

Your note

Sign in to keep a note on APMD — it syncs with the Stock Master app.